(Reuters) - Pfizer /BioNTech and Moderna have been hit with patent lawsuits by other companies related to their COVID-19 vaccines. In the latest turn .
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the past year relating to sales of the Moderna and BioNTech/Pfizer COVID-19.
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the past year relating to sales of the Moderna and.
Issuer: CureVac / Key word(s): Quarter Results18.08.2022 / 13:05 The issuer is solely responsible for the content of this announcement.CureVac Announces Financial Results for the Second Quarter and First Half of 2022 and Provides Business Update Delivering on broad 2022 second-generation vaccine development program.